Desenvolvida como um agonista de mltiplos receptores hormonais, a retatrutida atua simultaneamente nos receptores de GLP-1, GIP e glucagon, oferecendo uma abordagem inovadora no tratamento da obesidade
Severe allergic reactions: Difficulty breathing, severe rash, swelling of face or throat, or rapid heartbeat require emergency care (call 911)
For a frame of reference, tirzepatide achieved less than 20% weight loss at 36 weeks in their phase 2 trial
Selective Inhibition of BET bromodomains
Its specifically licensed and effective for blood sugar control
Each dose increase can trigger a new round of nausea, which typically peaks 2-3 days after the increase and fades over 1-2 weeks